Hillsdale Investment Management Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,514,429
-38.3%
37,237
-26.5%
0.14%
-33.8%
Q1 2023$2,452,856
-34.7%
50,637
-48.5%
0.21%
-33.8%
Q4 2022$3,753,523
-25.5%
98,337
-2.0%
0.32%
-30.3%
Q3 2022$5,037,000
+6357.7%
100,337
+4262.5%
0.46%
+4450.0%
Q2 2018$78,0002,3000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders